Ads Top

Potential COVID-19 drug: Zydus Cadila inks licensing pact with Gilead for remdesivir

Remdesivir, the investigational drug from Gilead Sciences Inc, has been issued an 'emergency use authorisation' (EUA) by the United States Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of coronavirus, Zydus Cadila said in a statement.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...

No comments:

Powered by Blogger.